These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23171166)

  • 21. Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France.
    Payet S; Denis P; Berdeaux G; Launois R
    Clin Drug Investig; 2008; 28(3):183-98. PubMed ID: 18266403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucoma.
    Holló G; Kóthy P; Géczy A; Vargha P
    J Glaucoma; 2009; 18(4):288-92. PubMed ID: 19365193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
    Kymes S
    Am J Ophthalmol; 2006 Aug; 142(2):354; author reply 354-5. PubMed ID: 16876536
    [No Abstract]   [Full Text] [Related]  

  • 25. A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy.
    Fain JM; Kotak S; Mardekian J; Bacharach J; Edward DP; Rauchman S; Brevetti T; Fox JL; Lovelace C
    BMC Ophthalmol; 2011 Jun; 11():13. PubMed ID: 21668980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.
    Schwartz GF; Tan J; Kotak S
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):555-61. PubMed ID: 20028264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Travoprost/timolol fixed combination.
    Herceg M; Noecker R
    Expert Opin Pharmacother; 2008 Apr; 9(6):1059-65. PubMed ID: 18377347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
    Li N; Chen XM; Zhou Y; Wei ML; Yao X
    Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular hypotensive efficacy and safety of travoprost 0.004% in inadequately controlled primary open-angle glaucoma or ocular hypertension: short-term, multicenter, prospective study.
    Blini M; Rossi GC; Trabucchi G; Curatola MR; David A; Radaelli R; Merlo G; Ratiglia R
    Curr Med Res Opin; 2009 Jan; 25(1):57-63. PubMed ID: 19210139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
    Cantor LB; WuDunn D; Cortes A; Hoop J; Knotts S
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S12-8. PubMed ID: 15016557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of medication adherence to topical glaucoma therapy.
    Dreer LE; Girkin C; Mansberger SL
    J Glaucoma; 2012; 21(4):234-40. PubMed ID: 21623223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin analog treatment of glaucoma and ocular hypertension.
    Alexander CL; Miller SJ; Abel SR
    Ann Pharmacother; 2002 Mar; 36(3):504-11. PubMed ID: 11895065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.
    Berenson KL; Kymes S; Hollander DA; Fiscella R; Burk C; Patel VD
    Am J Manag Care; 2011 Sep; 17(9):e365-74. PubMed ID: 21902444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension.
    Peace JH; Ahlberg P; Wagner M; Lim JM; Wirta D; Branch JD
    Am J Ophthalmol; 2015 Aug; 160(2):266-274.e1. PubMed ID: 25935098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of glaucoma in clinical practice: four-year results from a patient registry in France.
    Kobelt G; Texier-Richard B; Buchholz P; Bron A; Renard JP; Rouland JF; Nordmann JP
    J Glaucoma; 2010 Mar; 19(3):199-206. PubMed ID: 19661825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pressure lowering efficacy and safety of travoprost 0.004% as a replacement therapy in patients with open angle glaucoma or ocular hypertension.
    Ge J; Sun XH; Wang NL; Zhao JL; Wu LL; Chen XM; Wang ZX; Li B
    Chin Med J (Engl); 2010 Jun; 123(11):1417-21. PubMed ID: 20819599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
    Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.